Stock Events

Stock Events

Genomma Lab Internacional SAB 

M$18.12
31
+M$0.73+4.2% Tuesday 19:59

Statistics

Day High
18.2
Day Low
17.33
52W High
26.06
52W Low
15.89
Volume
2,812,049
Avg. Volume
3,500,824
Mkt Cap
18.12B
P/E Ratio
13.58
Dividend Yield
4.42%
Dividend
0.8

Upcoming

30
JUN
Dividend Ex
Estimated
 
1
JUL
Dividend Payment
Estimated
 
18
SEP
Dividend Ex
Estimated
 
18
SEP
Dividend Payment
Estimated
 
22
DEC
Dividend Ex
Estimated
 

Dividends

4.42%Dividend Yield
Mar 26
M$0.2
Dec 25
M$0.2
Sep 25
M$0.2
Jul 25
M$0.2
Mar 25
M$0.2
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
0.66%
1Y Growth
-25%

Earnings

29AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.02
0.02
0.03
0.04
Expected EPS
0.0248319
Actual EPS
N/A

Financials

6.87%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
55.82BRevenue
3.84BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABB.MX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals and consumer health sectors, directly competing with Genomma Lab's range of over-the-counter and personal care products.
Procter & Gamble
PG
Mkt Cap351.37B
Procter & Gamble offers a wide range of consumer health and personal care products, competing in similar markets as Genomma Lab.
Bayer
BAYRY
Mkt Cap30.63B
Bayer AG's consumer health division produces over-the-counter drugs and nutritional supplements, competing with Genomma Lab's product portfolio.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline, with its consumer healthcare division, competes in the over-the-counter medication market, similar to Genomma Lab.
Pfizer
PFE
Mkt Cap140.15B
Pfizer has a consumer healthcare division that produces over-the-counter medications, directly competing with Genomma Lab's offerings.
Novartis
NVS
Mkt Cap237.61B
Novartis operates in the pharmaceuticals sector, including over-the-counter drugs, competing with Genomma Lab's range of products.
Sanofi
SNY
Mkt Cap124.45B
Sanofi offers a broad portfolio of over-the-counter products, competing in the same space as Genomma Lab.
Merck
MRK
Mkt Cap214.76B
Merck, through its various healthcare products, competes in the pharmaceutical and consumer health markets, overlapping with Genomma Lab's market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, with its focus on pharmaceuticals, has a range of products that compete in the healthcare sector alongside Genomma Lab.
Church & Dwight
CHD
Mkt Cap21.36B
Church & Dwight offers a variety of household and personal care products, competing in the consumer goods sector alongside Genomma Lab.

About

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Show more...
CEO
Mr. Jorge Luis Brake Valderrama
Employees
2297
Country
Mexico
ISIN
MX01LA010006

Listings

OTC Link
US
GNMLF
MX
MX
LABB.MX
F
DE
GEKA.F

0 Comments

Share your thoughts

FAQ

What is Genomma Lab Internacional SAB stock price today?▼
The current price of LABB.MX is M$18.12 MXN — it has increased by +4.2% in the past 24 hours. Watch Genomma Lab Internacional SAB stock price performance more closely on the chart.
What is Genomma Lab Internacional SAB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genomma Lab Internacional SAB stocks are traded under the ticker LABB.MX.
Is Genomma Lab Internacional SAB stock price growing?▼
LABB.MX stock has risen by +2.9% compared to the previous week, the month change is a -0.88% fall, over the last year Genomma Lab Internacional SAB has showed a -27.69% decrease.
What is Genomma Lab Internacional SAB market cap?▼
Today Genomma Lab Internacional SAB has the market capitalization of 18.12B
When is the next Genomma Lab Internacional SAB earnings date?▼
Genomma Lab Internacional SAB is going to release the next earnings report on April 29, 2026.
What were Genomma Lab Internacional SAB earnings last quarter?▼
LABB.MX earnings for the last quarter are 0.31 MXN per share, whereas the estimation was 0.37 MXN resulting in a -17.95% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Genomma Lab Internacional SAB revenue for the last year?▼
Genomma Lab Internacional SAB revenue for the last year amounts to 55.82B MXN.
What is Genomma Lab Internacional SAB net income for the last year?▼
LABB.MX net income for the last year is 3.84B MXN.
Does Genomma Lab Internacional SAB pay dividends?▼
Yes, LABB.MX dividends are paid quarterly. The last dividend per share was 0.2 MXN. As of today, Dividend Yield (FWD)% is 4.42%.
How many employees does Genomma Lab Internacional SAB have?▼
As of April 01, 2026, the company has 2,297 employees.
In which sector is Genomma Lab Internacional SAB located?▼
Genomma Lab Internacional SAB operates in the Healthcare sector.
When did Genomma Lab Internacional SAB complete a stock split?▼
The last stock split for Genomma Lab Internacional SAB was on August 03, 2010 with a ratio of 2:1.
Where is Genomma Lab Internacional SAB headquartered?▼
Genomma Lab Internacional SAB is headquartered in Mexico City, Mexico.